BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32484824)

  • 41. Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study.
    Smolina K; Hanley GE; Mintzes B; Oberlander TF; Morgan S
    PLoS One; 2015; 10(5):e0128312. PubMed ID: 26011706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of overlapping prescriptions of psychotropic drugs by community pharmacists.
    Shimane T; Matsumoto T; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Oct; 47(5):202-10. PubMed ID: 23393998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway.
    Fredheim OM; Skurtveit S; Breivik H; Borchgrevink PC
    Eur J Pain; 2010 Mar; 14(3):289-94. PubMed ID: 19505834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of prescription medicines in Australian women of child-bearing age.
    Gadzhanova S; Roughead E
    BMC Pharmacol Toxicol; 2015 Dec; 16():33. PubMed ID: 26643036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dispensing behaviour of pharmacies in prescription drug markets.
    Guhl D; Stargardt T; Schneider U; Fischer KE
    Health Policy; 2016 Feb; 120(2):190-7. PubMed ID: 26874903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of medicines use pattern using World Health Organization's Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia.
    Bilal AI; Osman ED; Mulugeta A
    BMC Health Serv Res; 2016 Apr; 16():144. PubMed ID: 27106610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Equity in Prescription Medicines Use Study: using community pharmacy databases to study medicines utilisation.
    Horsburgh S; Norris P; Becket G; Crampton P; Arroll B; Cumming J; Herbison P; Sides G
    J Biomed Inform; 2010 Dec; 43(6):982-7. PubMed ID: 20709187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linking community pharmacy dispensing data to prescribing data of general practitioners.
    Florentinus SR; Souverein PC; Griens FA; Groenewegen PP; Leufkens HG; Heerdink ER
    BMC Med Inform Decis Mak; 2006 Apr; 6():18. PubMed ID: 16584557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1).
    Kerr A; Exeter D; Hanham G; Grey C; Zhao J; Riddell T; Lee M; Jackson R; Wells S
    N Z Med J; 2014 Aug; 127(1400):39-69. PubMed ID: 25145366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prescription drug use among pregnant women in opioid Maintenance Treatment.
    Lund IO; Skurtveit S; Engeland A; Furu K; Ravndal E; Handal M
    Addiction; 2013 Feb; 108(2):367-76. PubMed ID: 22882166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of other opioids during methadone therapy: a population-based study.
    Kurdyak P; Gomes T; Yao Z; Mamdani MM; Hellings C; Fischer B; Rehm J; Bayoumi AM; Juurlink DN
    Addiction; 2012 Apr; 107(4):776-80. PubMed ID: 22050078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.
    Engeland A; Bramness JG; Daltveit AK; Rønning M; Skurtveit S; Furu K
    Br J Clin Pharmacol; 2008 May; 65(5):653-60. PubMed ID: 18294334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges of using primary care electronic medical records in the UK to study medications in pregnancy.
    Cea-Soriano L; García Rodríguez LA; Fernández Cantero O; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):977-85. PubMed ID: 23813653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating prescriptions for the elderly: drug/age criteria as a tool to help community pharmacists.
    Mott DA; Meek PD
    J Am Pharm Assoc (Wash); 2000; 40(3):417-24. PubMed ID: 10853543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
    Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
    BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of the rates and characteristics of unclaimed prescriptions.
    Delate T; Kastendieck D
    J Am Pharm Assoc (2003); 2017; 57(3):349-355. PubMed ID: 28238663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sociodemographic variation in prescriptions dispensed in early pregnancy in Northern Ireland 2010-2016.
    Given J; Casson K; Dolk H; Loane M
    PLoS One; 2022; 17(8):e0267710. PubMed ID: 35994459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study.
    Choremis B; Campbell T; Tadrous M; Martins D; Antoniou T; Gomes T
    PLoS One; 2019; 14(10):e0223589. PubMed ID: 31626648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
    Halkin H; Katzir I; Kurman I; Jan J; Malkin BB
    Clin Pharmacol Ther; 2001 Apr; 69(4):260-5. PubMed ID: 11309555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.